Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 2018 | 2320 | 42.5 | 74% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 2082 | 4782 | CHIM BIOINORGAN//CARBONIC ANHYDRASE//SEZ SCI FARMACEUT |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | CHIM BIOINORGAN | Address | 875 | 85% | 20% | 469 |
| 2 | CARBONIC ANHYDRASE | Author keyword | 283 | 33% | 30% | 703 |
| 3 | SEZ SCI FARMACEUT | Address | 126 | 95% | 2% | 41 |
| 4 | SEZ SCI FARMACEUT NUTRACEUT | Address | 89 | 90% | 2% | 38 |
| 5 | BETA CLASS ENZYME | Author keyword | 76 | 100% | 1% | 24 |
| 6 | POLO SCI | Address | 73 | 60% | 3% | 81 |
| 7 | CARBONIC ANHYDRASE IX | Author keyword | 72 | 53% | 4% | 96 |
| 8 | SECT PHARMACEUT NUTRICEUT SCI | Address | 65 | 93% | 1% | 25 |
| 9 | NEUROFARBA | Address | 61 | 42% | 5% | 110 |
| 10 | SULFONAMIDE | Author keyword | 53 | 24% | 8% | 195 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | CARBONIC ANHYDRASE | 283 | 33% | 30% | 703 | Search CARBONIC+ANHYDRASE | Search CARBONIC+ANHYDRASE |
| 2 | BETA CLASS ENZYME | 76 | 100% | 1% | 24 | Search BETA+CLASS+ENZYME | Search BETA+CLASS+ENZYME |
| 3 | CARBONIC ANHYDRASE IX | 72 | 53% | 4% | 96 | Search CARBONIC+ANHYDRASE+IX | Search CARBONIC+ANHYDRASE+IX |
| 4 | SULFONAMIDE | 53 | 24% | 8% | 195 | Search SULFONAMIDE | Search SULFONAMIDE |
| 5 | ISOFORM SELECTIVE INHIBITOR | 32 | 85% | 1% | 17 | Search ISOFORM+SELECTIVE+INHIBITOR | Search ISOFORM+SELECTIVE+INHIBITOR |
| 6 | HCA II | 26 | 87% | 1% | 13 | Search HCA+II | Search HCA+II |
| 7 | CA IX | 26 | 53% | 1% | 34 | Search CA+IX | Search CA+IX |
| 8 | BETA CARBONIC ANHYDRASE | 26 | 80% | 1% | 16 | Search BETA+CARBONIC+ANHYDRASE | Search BETA+CARBONIC+ANHYDRASE |
| 9 | ENZYME ACTIVATOR | 26 | 80% | 1% | 16 | Search ENZYME+ACTIVATOR | Search ENZYME+ACTIVATOR |
| 10 | HCA I | 24 | 91% | 0% | 10 | Search HCA+I | Search HCA+I |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | HETEROCYCLIC SULFONAMIDES | 250 | 94% | 4% | 90 |
| 2 | ISOZYME II | 243 | 77% | 7% | 167 |
| 3 | ANTITUMOR SULFONAMIDE | 162 | 100% | 2% | 43 |
| 4 | MN CA IX | 151 | 86% | 3% | 76 |
| 5 | AROMATIC HETEROCYCLIC SULFONAMIDES | 139 | 82% | 3% | 80 |
| 6 | ISOZYME IX | 121 | 72% | 4% | 96 |
| 7 | ISOFORMS I | 115 | 100% | 1% | 33 |
| 8 | CA IX | 102 | 69% | 4% | 88 |
| 9 | THERAPEUTIC APPLICATIONS | 98 | 31% | 11% | 263 |
| 10 | SULFAMATE INHIBITORS | 94 | 97% | 1% | 28 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: From biology to clinical use | 2015 | 4 | 170 | 68% |
| Carbonic anhydrases: novel therapeutic applications for inhibitors and activators | 2008 | 472 | 102 | 85% |
| Carbonic anhydrase inhibitors | 2003 | 640 | 130 | 78% |
| Structural annotation of human carbonic anhydrases | 2013 | 38 | 86 | 73% |
| Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms? | 2012 | 61 | 294 | 73% |
| Carbonic anhydrases as targets for medicinal chemistry | 2007 | 131 | 53 | 98% |
| Interfering with pH regulation in tumours as a therapeutic strategy | 2011 | 145 | 108 | 43% |
| Update on carbonic anhydrase inhibitors: a patent review (2008-2011) | 2012 | 38 | 94 | 85% |
| Bacterial carbonic anhydrases as drug targets: toward novel antibiotics? | 2011 | 65 | 51 | 75% |
| Carbonic anhydrases - An overview | 2008 | 119 | 52 | 96% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CHIM BIOINORGAN | 875 | 85% | 20% | 469 |
| 2 | SEZ SCI FARMACEUT | 126 | 95% | 1.8% | 41 |
| 3 | SEZ SCI FARMACEUT NUTRACEUT | 89 | 90% | 1.6% | 38 |
| 4 | POLO SCI | 73 | 60% | 3.5% | 81 |
| 5 | SECT PHARMACEUT NUTRICEUT SCI | 65 | 93% | 1.1% | 25 |
| 6 | NEUROFARBA | 61 | 42% | 4.7% | 110 |
| 7 | CHIM INORGAN BIOINORGAN | 39 | 43% | 3.0% | 70 |
| 8 | DIPARTIMENTO NEUROFARBA | 30 | 79% | 0.8% | 19 |
| 9 | SECT PHARMACEUT CHEM | 25 | 77% | 0.7% | 17 |
| 10 | CHIM BIOORGAN | 22 | 17% | 5.0% | 117 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000216397 | CARBONIC ANHYDRASE VI//CARBONIC ANHYDRASE III//CARBONATE DEHYDRATASE |
| 2 | 0.0000188040 | BIOCHEM BIOPHYS BIOCHEM//FRACTOSIL//BIOMIMETIC CO2 SEQUESTRATION |
| 3 | 0.0000158815 | GIRENTUXIMAB//G250//MONOCLONAL ANTIBODY CG250 |
| 4 | 0.0000148667 | CHEM TECHNOL DRUGS//2 MERCAPTOBENZENESULFONAMIDE//2 MERCAPTOBENZENESULFONAMIDES |
| 5 | 0.0000070216 | CARBONIC ACID//AUTOCATALYTIC DECOMPOSITION REACTION//PROTON TRANSFER BARRIERS |
| 6 | 0.0000069164 | SULFONAMIDE LIGANDS//SULFATHIAZOLE COMPLEXES//N SUBSTITUTED SULFONAMIDES |
| 7 | 0.0000068603 | DRUG RADIAT//M PRC//RADIOPROTECTIVE AGENTS |
| 8 | 0.0000054531 | UNIDADE RAIOS X RIAIDT VICERRECTORADO INVEST//BISTRIDENTATE//HYDROGENPHOSPHATE COMPLEXES |
| 9 | 0.0000053366 | VNP40101M//CLORETAZINE//NEW ANTICANCER AGENT |
| 10 | 0.0000051589 | ZINC PROTEINS//DRUG DESIGN BIOTECHNOL//METALLOPROTEOME |